Life Science

An inhibitor of Nampt and NF-&kappaB pathway activity potent cytotoxic effects in human breast (IC50 = 7.3 nM) and lung cancer (IC50 = 0.

An inhibitor of Nampt and NF-&kappaB pathway activity potent cytotoxic effects in human breast (IC50 = 7.3 nM) and lung cancer (IC50 = 0.

cHTR Reagent - 50 mL

A potent inhibitor of chymotrypsin and chymase (Ki = 9.36 and 13.1 nM, respectively), that less effectively blocks the activity of cathepsins, papain, and leukocyte elastase.

A potent inhibitor of chymotrypsin and chymase (Ki = 9.36 and 13.1 nM, respectively), that less effectively blocks the activity of cathepsins, papain, and leukocyte elastase.

A potent inhibitor of chymotrypsin and chymase (Ki = 9.36 and 13.1 nM, respectively), that less effectively blocks the activity of cathepsins, papain, and leukocyte elastase.

A potent inhibitor of MEK in (IC50 = 2.3 nM Kd = 74 nM when activated with ATP) that suppresses phosphorylation of ERK in mouse colon 26 tumors (IC50 = 35 nM).

A potent inhibitor of MEK in (IC50 = 2.3 nM Kd = 74 nM when activated with ATP) that suppresses phosphorylation of ERK in mouse colon 26 tumors (IC50 = 35 nM).

A potent inhibitor of MEK in (IC50 = 2.3 nM Kd = 74 nM when activated with ATP) that suppresses phosphorylation of ERK in mouse colon 26 tumors (IC50 = 35 nM).

A potent inhibitor of MEK in (IC50 = 2.3 nM Kd = 74 nM when activated with ATP) that suppresses phosphorylation of ERK in mouse colon 26 tumors (IC50 = 35 nM).

A potent, selective, orally bioavailable inhibitor of ACAT-1 (IC₅₀ = 73 nM).

A potent, selective, orally bioavailable inhibitor of ACAT-1 (IC₅₀ = 73 nM).